1 active not recruiting, 1 completed, 1 terminated, 1 withdrawn. 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Terminated 1 |
| Not applicable | 1 | Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow NRTI: new trials by email Literature Review of NRTI trials Research Report on NRTI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection. VIR-2218, VIR-3434, NRTI - Hepatitis D, Chronic | Phase 2 | Active not recruiting | Vir Biotechnology, Inc. | 95 | 2022-09-17 | 2026-06-26 |
| A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase Inhibitors ABI-H0731, Placebo, NrtI - Chronic Hepatitis B | Phase 2 | Terminated | Assembly Biosciences | 2 | 2020-11-11 | 2022-10-20 |
| Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment E/C/F/TDF, COBI, ATV - Acquired Immunodeficiency Syndrome, HIV Infections | Phase 3 | Completed | Gilead Sciences | 106 | 2011-05-01 | 2016-05-02 |
| Raltegravir Activity In Lymphoid Tissues Efavirenz + Tenofovir DF/Emtricitabine, Raltegravir + Tenofovir DF/Emtricitabine, Colonoscopy with biopsies - HIV Infection, HIV Infections | Not applicable | Withdrawn | University of Minnesota | 2009-03-01 | 2015-05-18 |
HIV Infections (2) · Acquired Immunodeficiency Syndrome (1) · Hepatitis (1) · Hepatitis B, Chronic (1) · Hepatitis D (1) · Hepatitis D, Chronic (1) · Infections (1)
Assembly Biosciences (1) · Gilead Sciences (1) · University of Minnesota (1) · Vir Biotechnology, Inc. (1)
United States (3) · Germany (2) · New Zealand (2) · United Kingdom (2) · Australia (1) · Austria (1) · Bulgaria (1) · Canada (1) · Dominican Republic (1) · France (1) · Hong Kong (1) · Italy (1) · Mexico (1) · Moldova (1) · Netherlands (1)
Javier Szwarcberg, MD (1) · Steven Knox (1) · Timothy W Schacker, M.D. (1)